REGAIN

CONTROL

MEET MUVON

OUR STORY

MUVON Therapeutics is a Life Science Spin-off from the University of Zurich with the goal of developing and commercializing an autologous cell therapy for the regeneration of skeletal muscle tissue. Our initial area of focus is developing a safe and effective treatment for stress urinary incontinence in women, supporting them respectfully throughout their journey to a healthy life.

OUR VISION

Together, we aim to establish personalized therapeutic solutions as the primary standard of care. Our goal is to offer the patients in need minimally invasive, low-risk treatments for the regeneration of skeletal muscle tissue, to help them regain control over their life.

OUR TECHNOLOGY

MUVON Therapeutics is developing an autologous cell therapy for the treatment of diseases related to skeletal muscle damage or degradation. Our technology enables the targeted isolation of muscle precursor cells (MPCs) from muscle tissue, the controlled expansion of these cells and the regeneration of muscle tissue through injection of the expanded cells.

Active recruitment for our Phase I clinical trial is completed. Interested in more information or joining future trials?  
muvon_therapeutics_icon.png

SUPPORT &
AWARDS

Wyss-no-background.png
TDA_lkd.png
WSS_Logo_16mm_600_rgb.png
BEI_Logo_byline_RGB.png
USZ-Logo_quer_Blau_RGB.png
horizon2020-eu-commission-logo.png
co-funded-h2020-horiz_en.png
2021_VEN_Finalist_h&n_pos_RGB.png
 

NEWS

INTERESTED IN INVESTING ?

Interested in investing in this innovative regenerative therapy?